Intersnack Group will buy all Utz Class A shares for $14.25 each, a 91% premium that values the snack maker at roughly $2.9 billion. The deal splits ownership 50/50 between Intersnack and the Rice‑Lissette family, giving the German firm a foothold in the U.S. market while supplying Utz with global scale and innovation.
Candid Health just closed a $120 million Series D led by Sixth Street Growth, tripling its valuation and pushing annual recurring revenue up 190% YoY. The AI‑driven billing platform aims to slash the $280 billion U.S. medical‑billing mess, promising near‑zero claim rejections and higher net collections for providers.
IREN sealed $2.8 billion in multi‑year AI cloud contracts with developers like Microsoft and NVIDIA, boosting its 2026 cloud ARR target to over $4 billion. About 85% of that target is already under contract, and pre‑payments cover roughly 45% of GPU cap‑ex, giving the company strong visibility and cash flow.
Data from StepStone’s SPI database shows the median EV/EBITDA for U.S. buyouts hit 12.5× in 2024, tying the 2021 record despite higher interest rates. Large‑cap deals ($1B+ EV) were priced at 16×, with sponsors funding the gap largely with equity, equity/EBITDA rose to 7.8×, the highest since 2015. The trend hints at fierce competition and a shift away from debt‑heavy financing.